TABLE 1.
Adverse factor | Points Assigned | No. % (n = 505) |
---|---|---|
Type of primary tumor | ||
Breast or Prostate | 0 | 87 (17.2) |
Lung or other | 1 | 418 (82.8) |
ECOG performance status | ||
0‐1 | 0 | 264 (52.3) |
2‐4 | 1 | 241 (47.7) |
Age (y) | ||
≤60 | 0 | 129 (25.5) |
>60 | 1 | 376 (74.5) |
Prior lines of palliative chemotherapy | ||
≤2 | 0 | 216 (42.8) |
>2 | 1 | 289 (57.2) |
Hepatic metastases | ||
Absent | 0 | 316 (62.6) |
Present | 1 | 189 (37.4) |
Hospitalizations in prior 3 mo | ||
No | 0 | 179 (35.4) |
Yes | 1 | 326 (64.6) |
Group (median life expectancy) | ||
A (19.9 mo) | 0‐1 | — |
B (5.0 mo) | 2‐4 | — |
C (1.7 mo) | 5‐6 | — |
Abbreviation: ECOG, Eastern Cooperative Oncology Group.